国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmonella paratyphi C Uracil phosphoribosyltransferase (upp) CSB-YP506427SWU
CSB-EP506427SWU
CSB-BP506427SWU
CSB-MP506427SWU
CSB-EP506427SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Glutamate-ammonia-ligase adenylyltransferase (glnE), partial CSB-YP506428SWU
CSB-EP506428SWU
CSB-BP506428SWU
CSB-MP506428SWU
CSB-EP506428SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C G/U mismatch-specific DNA glycosylase (mug) CSB-YP506429SWU
CSB-EP506429SWU
CSB-BP506429SWU
CSB-MP506429SWU
CSB-EP506429SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C UPF0102 protein yraN (yraN) CSB-YP506430SWU
CSB-EP506430SWU
CSB-BP506430SWU
CSB-MP506430SWU
CSB-EP506430SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Phosphoglucosamine mutase (glmM) CSB-YP506431SWU
CSB-EP506431SWU
CSB-BP506431SWU
CSB-MP506431SWU
CSB-EP506431SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C GTPase obg (obg) CSB-YP506432SWU
CSB-EP506432SWU
CSB-BP506432SWU
CSB-MP506432SWU
CSB-EP506432SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 30S ribosomal protein S9 (rpsI) CSB-YP506433SWU
CSB-EP506433SWU
CSB-BP506433SWU
CSB-MP506433SWU
CSB-EP506433SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 50S ribosomal protein L18 (rplR) CSB-YP506434SWU
CSB-EP506434SWU
CSB-BP506434SWU
CSB-MP506434SWU
CSB-EP506434SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C UPF0208 membrane protein YfbV (yfbV), partial CSB-YP506435SWU1
CSB-EP506435SWU1
CSB-BP506435SWU1
CSB-MP506435SWU1
CSB-EP506435SWU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Ribonuclease BN (rbn) CSB-YP506436SWU
CSB-EP506436SWU
CSB-BP506436SWU
CSB-MP506436SWU
CSB-EP506436SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Bifunctional polymyxin resistance protein ArnA (arnA), partial CSB-YP506437SWU
CSB-EP506437SWU
CSB-BP506437SWU
CSB-MP506437SWU
CSB-EP506437SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 50S ribosomal protein L24 (rplX) CSB-YP506438SWU
CSB-EP506438SWU
CSB-BP506438SWU
CSB-MP506438SWU
CSB-EP506438SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C 30S ribosomal protein S10 (rpsJ) CSB-YP506439SWU
CSB-EP506439SWU
CSB-BP506439SWU
CSB-MP506439SWU
CSB-EP506439SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Glutathione-regulated potassium-efflux system protein KefB (kefB), partial CSB-YP506440SWU
CSB-EP506440SWU
CSB-BP506440SWU
CSB-MP506440SWU
CSB-EP506440SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Pimelyl-[acyl-carrier protein] methyl ester esterase (bioH) CSB-YP506441SWU
CSB-EP506441SWU
CSB-BP506441SWU
CSB-MP506441SWU
CSB-EP506441SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Nucleoid-associated protein YejK (yejK) CSB-YP506442SWU
CSB-EP506442SWU
CSB-BP506442SWU
CSB-MP506442SWU
CSB-EP506442SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Methionine--tRNA ligase (metG), partial CSB-YP506443SWU
CSB-EP506443SWU
CSB-BP506443SWU
CSB-MP506443SWU
CSB-EP506443SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Glycine--tRNA ligase beta subunit (glyS), partial CSB-YP506444SWU
CSB-EP506444SWU
CSB-BP506444SWU
CSB-MP506444SWU
CSB-EP506444SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Multidrug resistance protein MdtA (mdtA) CSB-YP506445SWU
CSB-EP506445SWU
CSB-BP506445SWU
CSB-MP506445SWU
CSB-EP506445SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmonella paratyphi C Imidazole glycerol phosphate synthase subunit HisF (hisF) CSB-YP506446SWU
CSB-EP506446SWU
CSB-BP506446SWU
CSB-MP506446SWU
CSB-EP506446SWU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>